valyl-glycyl-valyl-alanyl-prolyl-glycine has been researched along with arginyl-glycyl-aspartyl-serine in 1 studies
| Studies (valyl-glycyl-valyl-alanyl-prolyl-glycine) | Trials (valyl-glycyl-valyl-alanyl-prolyl-glycine) | Recent Studies (post-2010) (valyl-glycyl-valyl-alanyl-prolyl-glycine) | Studies (arginyl-glycyl-aspartyl-serine) | Trials (arginyl-glycyl-aspartyl-serine) | Recent Studies (post-2010) (arginyl-glycyl-aspartyl-serine) |
|---|---|---|---|---|---|
| 37 | 1 | 19 | 503 | 0 | 79 |
| Protein | Taxonomy | valyl-glycyl-valyl-alanyl-prolyl-glycine (IC50) | arginyl-glycyl-aspartyl-serine (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 4.17 | |
| Integrin beta-1 | Homo sapiens (human) | 2.2 | |
| Integrin alpha-IIb | Homo sapiens (human) | 4.17 | |
| Integrin alpha-5 | Homo sapiens (human) | 2.2 | |
| Integrin beta | Oryctolagus cuniculus (rabbit) | 5.1 | |
| Glycoprotein IIb | Oryctolagus cuniculus (rabbit) | 5.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anseth, KS; Gould, ST | 1 |
1 other study(ies) available for valyl-glycyl-valyl-alanyl-prolyl-glycine and arginyl-glycyl-aspartyl-serine
| Article | Year |
|---|---|
Role of cell-matrix interactions on VIC phenotype and tissue deposition in 3D PEG hydrogels.
Topics: Animals; Cells, Cultured; Collagen; Extracellular Matrix; Heart Valves; Hydrogels; Oligopeptides; Peptide Fragments; Polyethylene Glycols; Swine | 2016 |